Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.
about
Current trends in management of hepatitis B virus reactivation in the biologic therapy eraManagement of hepatitis B reactivation in immunosuppressed patients: An update on current recommendationsHepatitis B and Hepatitis C Reactivation in the Biologic EraClinical impact of occult hepatitis B virus infection in immunosuppressed patientsAcute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis BProphylactic Measures During Induction for Acute Myeloid Leukemia.Natural history of chronic hepatitis B: phases in a complex relationship.Review article: prescribing medications in patients with cirrhosis - a practical guide.Febrile neutropenia in hematologic malignancies.Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.S-phase arrest after vincristine treatment may promote hepatitis B virus replicationThe compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder systemA fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier.Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma.Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management.Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.The management of chronic hepatitis B in Asian Americans.Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management.Patients with hematological malignancies and serological signs of prior resolved hepatitis B.Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries.Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia.HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.Prevalence of occult hepatitis B infection in patients visiting tertiary care hospitalStopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience.Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey.Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.Hepatitis B inactive carriers: clinical course and outcomes.Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic.Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy.Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.
P2860
Q24634879-3E60DB6D-E80D-4D0C-8F3D-C7280C0A0405Q26752690-BFD5C325-9637-4FA9-9130-91C2A58B52CEQ26781993-45F86E07-A60F-40D3-BE4A-50ADDF899624Q27006996-E4AB7C77-D4DE-49BF-B86A-AE653505140BQ27022622-B5C73E98-1096-4E52-B1A3-1CE959420B55Q30235496-00C3E03C-FF17-4679-9CC5-4CEBBA501062Q34036650-26A591E1-577C-400C-880E-CD7977611F80Q34342554-CE716C9D-5A3E-4838-B85D-AF361E1F08E9Q34655730-6D079DBF-C23F-4AF9-AB36-756F025A5D6BQ34974883-83479210-A95B-46FD-B2D7-CC2854247747Q35045736-FC93B284-C612-42C0-8DC8-0D6EE471FE0CQ35057889-3E564432-D19C-48A8-B059-22ADA53EF8E6Q36154001-C6E5FCB4-0688-45F5-9B7B-40B9F7672183Q36225933-DF6AFBAD-0E7E-4ADD-846F-955B53E4CD4BQ36245362-4A6A1AE6-FCAA-4011-8FBF-37828298CDBCQ36406054-69D16624-496A-42E3-B932-0D9B35F8387BQ36957087-696DE62A-C320-4FE9-B893-5D68E3C9B92EQ37936321-7C410FE2-02D7-4610-AEBB-E4AF60255456Q37970447-38F2BC82-AE21-4AEA-9A5C-1C4FEAB41177Q37999022-6D11B41B-32D8-4C24-BE4C-E0BCA09B32F2Q38388198-AF3AA1BD-5128-4544-B91E-9679DA577E15Q40003713-6BCE30AA-4F94-44FA-A248-93AF4FBF2456Q40633899-C21C8117-D31C-40C9-B303-BF8CF69967CBQ40647527-9F2C07BA-E0D0-4F60-BF30-FA4E22B6EF98Q40691267-29C8D1C8-EE66-43B6-B499-6CE88B04E0E8Q41482859-F5A48415-9CE6-48C2-AD40-4026D11B420AQ41526311-E4DF7560-2A4D-4EFD-96CC-7909228DE283Q42227093-3A8918D0-4220-432C-B3BC-5171A7295090Q42240548-B30EA1FF-084D-4C6D-BFE8-2B27594F9D65Q45268408-8CC98102-32B5-400C-8E2C-0CF8D2CAFAE8Q45292056-0950663F-40F7-444C-9FA5-7A4A48B21744Q45355599-89F4184F-2469-4F2F-8383-AD8CC9D75D94Q45356997-90E1BABD-87A9-4E0F-B4B0-83B852313FBEQ46242353-C35547B7-5358-45C0-B833-6FA34000FA2BQ52618967-5BCB6CF1-B3C4-4E57-8AF1-00CFEE604C05
P2860
Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@en
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@nl
type
label
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@en
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@nl
prefLabel
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@en
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@nl
P2860
P921
P1476
Hepatitis B reactivation in pa ...... apy: diagnosis and management.
@en
P2093
John S Lubel
Peter W Angus
P2860
P304
P356
10.1111/J.1440-1746.2010.06243.X
P577
2010-05-01T00:00:00Z